当提安明多®630商标落地，“德国精度”在此刻形成闭环

Core Viewpoint - Bayer's new product, Thiamidol 630, represents a significant milestone in the integration of global research and local market needs, showcasing a model of innovation that combines "German precision" with "Shanghai speed" [3][4][24]. Group 1: Product Development and Market Integration - Thiamidol 630 is the second new whitening ingredient approved in China and the first to receive approval after the implementation of the Cosmetics Supervision and Administration Regulations in 2021, marking a significant achievement in localizing global innovations [5][24]. - The product's development process, referred to internally as the "211 project," took nine years and reflects Bayer's commitment to thorough research and development [5][11]. - The unveiling of the Chinese trademark for Thiamidol 630 signifies Bayer's deepening integration into the Chinese market and its role as a key node in the company's global research network [5][11][23]. Group 2: Research and Innovation Strategy - Bayer's strategy emphasizes a dual approach of "global innovation + local insight," which drives the company's research and development efforts in China [18][21]. - The company has established a comprehensive research framework that includes basic research, clinical validation, and market transformation, creating a closed-loop system that enhances product efficacy and safety [18][21][26]. - Thiamidol 630's clinical data shows significant improvements in skin conditions after 12 weeks of use, demonstrating its effectiveness and safety compared to traditional whitening agents [16][18]. Group 3: Industry Impact and Future Directions - The successful launch of Thiamidol 630 serves as a model for international brands navigating the Chinese regulatory landscape, providing a pathway for future cross-border research collaborations [26][27]. - The product's introduction is expected to shift industry standards towards more scientifically validated approaches in skincare, moving away from traditional models that rely on less effective ingredients [26][27]. - Bayer's commitment to rigorous scientific validation and consumer safety positions it as a leader in the skincare industry, reinforcing its brand strength and market presence in China [27][28].